| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
| 07/27/2005 | EP1556051A2 Synergistic methods and compositions for treating cancer |
| 07/27/2005 | EP1556050A1 Pharmaceutical compositions of ganciclovir |
| 07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 07/27/2005 | EP1556048A1 Effervescent formulations comprising apomorphine |
| 07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/27/2005 | EP1556045A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 07/27/2005 | EP1556044A2 Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 07/27/2005 | EP1556042A2 Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain |
| 07/27/2005 | EP1556041A1 A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556038A2 Acetophenone potentiators of metabotropic glutamate receptors |
| 07/27/2005 | EP1556036A2 Use of iminosugar derivatives to inhibit ion channel activity |
| 07/27/2005 | EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 07/27/2005 | EP1556034A1 Indole derivatives as beta-2 agonists |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556032A1 Agent for preventing or treating neuropathy |
| 07/27/2005 | EP1556031A2 Chromones and chromone derivatives and uses thereof |
| 07/27/2005 | EP1556030A2 Taxane metabolites |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1556028A1 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
| 07/27/2005 | EP1556027A1 Modified amino acid for the inhibition of platelet aggregation |
| 07/27/2005 | EP1556026A1 Novel pharmaceutical formulations of modafinil |
| 07/27/2005 | EP1556025A1 Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries |
| 07/27/2005 | EP1556024A1 Pulsatile release compositions of milnacipran |
| 07/27/2005 | EP1556023A1 Nutritional or therapeutic compositions |
| 07/27/2005 | EP1556022A1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 07/27/2005 | EP1556021A1 Pharmaceutical compositions comprising flavonoids and menthol |
| 07/27/2005 | EP1556020A2 Use of cgrp antagonist compounds for treatment of psoriasis |
| 07/27/2005 | EP1556019A2 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 07/27/2005 | EP1556018A1 Sustained release porous microparticles for inhalation |
| 07/27/2005 | EP1556016A1 Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 07/27/2005 | EP1556015A1 Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 07/27/2005 | EP1556014A1 Sustained release compositions containing alfuzosin |
| 07/27/2005 | EP1556013A1 Deferacirox dispersible tablets |
| 07/27/2005 | EP1556012A2 Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier |
| 07/27/2005 | EP1556011A1 Therapeutic compositions |
| 07/27/2005 | EP1556010A2 Pharmaceutical formulations targeting specific regions of the gastrointestinal tract |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1556007A2 Substituted tetracycline compounds for the treatment of malaria |
| 07/27/2005 | EP1556004A2 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 07/27/2005 | EP1556003A2 Methods of administering and enhancing absorption of pharmaceutical agents |
| 07/27/2005 | EP1556001A2 Therapeutic compositions for drug delivery to and through covering epithelia |
| 07/27/2005 | EP1556000A1 Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs |
| 07/27/2005 | EP1555976A2 Propofol with cysteine |
| 07/27/2005 | EP1555896A1 Methods and compositions for providing glutamine |
| 07/27/2005 | EP1455803B1 Pharmaceutical composition for use in ophthalmology and rhinology |
| 07/27/2005 | EP1432709B1 1-glyoxlylamide indolizines for treating cancer |
| 07/27/2005 | EP1414384A4 Synthesis of epothilones and relates analogs |
| 07/27/2005 | EP1387837B1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1318992B1 Imidazole derivatives as raf kinase inhibitors |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5 |
| 07/27/2005 | EP1309555B1 Process for making amlodipine maleate |
| 07/27/2005 | EP1305014B1 Use of (deaminohydroxy)toremifene for the treatment of vaginal dryness or sexual dysfunction during or after the menopause |
| 07/27/2005 | EP1296665A4 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1283709B1 Peptide deformylase inhibitors |
| 07/27/2005 | EP1276376B1 Active substance combinations with insecticidal and acaricidal properties |
| 07/27/2005 | EP1274411B1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1263444B1 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis |
| 07/27/2005 | EP1248622B1 Pharmaceutical composition comprising a metabolite of buspirone |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1235557B1 Gastroretentive controlled release pharmaceutical dosage forms |
| 07/27/2005 | EP1217999B1 The use of baclofen in the treatment of alcoholism |
| 07/27/2005 | EP1214063B1 Treating cancer using tetraethyl thiuram disulfide |
| 07/27/2005 | EP1206539B1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 07/27/2005 | EP1187601B1 Novel preparation and administration form comprising an acid-labile proton pump inhibitor |
| 07/27/2005 | EP1185527B1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 07/27/2005 | EP1183029B1 Pharmaceutical preparation containing diamorphine and vitamin e and its utilization for treating opiate addiction |
| 07/27/2005 | EP1148873B1 Highly purified ethyl epa and other epa derivatives for neurological disorders |
| 07/27/2005 | EP1143955B1 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 07/27/2005 | EP1124537B1 Propofol composition |
| 07/27/2005 | EP1107966B1 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands |
| 07/27/2005 | EP1077716B1 Preparation of a medicament for the treatment of gastroesophageal reflux disease |
| 07/27/2005 | EP1075268B1 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori |
| 07/27/2005 | EP1071403B1 Pharmaceutical composition containing a statin and aspirin |
| 07/27/2005 | EP1067896B1 Topical compositions comprising ascorbyl-phosphoryl-cholesterol |
| 07/27/2005 | EP1053018B1 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
| 07/27/2005 | EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | EP0996436B1 Pharmaceutical formulations containing poorly soluble drug substances |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | EP0973705B1 Chromatographic enantiomer separation of lactones |
| 07/27/2005 | EP0954299B1 Thyroxine analogues having no significant hormonal activity for treating malignant tumours |
| 07/27/2005 | EP0952855B1 Use of hyaluronan in gene therapy |
| 07/27/2005 | EP0942718B1 Coated trimebutine maleate tablet |
| 07/27/2005 | EP0935462B1 Photopheresis treatment of leukocytes |
| 07/27/2005 | EP0929526B1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 07/27/2005 | EP0799051B1 Irrigation solution and use thereof for perioperatively inhibiting pain, inflammation and spasm at a wound |
| 07/27/2005 | CN2712349Y Subcutaneous implantable sustained-release silica gel rod for antipsychotics |
| 07/27/2005 | CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |